Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-22

Clinical Trial Update: Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing levofloxacin-based triple therapy to clarithromycin-based triple therapy as first-line treatments for Helicobacter pylori eradication …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levofloxacin (Levofloxacin)
  • clarithromycin (clarithromycin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Helicobacter Infections | Phase 4 | Status: COMPLETED